Nasdaq Stockholm AB: Listing of IRLAB Therapeutics AB on Nasdaq Stockholm (121/20)

Nasdaq Stockholm AB has assessed that IRLAB Therapeutics AB, company
registration number 556931-4692, fulfills Nasdaq Stockholm's listing
requirements. Provided that IRLAB Therapeutics AB applies for admission to
trading of its shares on Nasdaq Stockholm, that the liquidity requirements will
be met and that IRLAB Therapeutics AB's prospectus is approved, first day of
trading is expected to September 30, 2020. The shares are currently traded on
Nasdaq First North Premier Growth Market. 


As per today's date the company has 48,418,630 common A- shares and 79,776
common B-shares. 


Short Name:                       IRLAB A                 
----------------------------------------------------------
Number of A-shares to be listed:  48,418,630              
----------------------------------------------------------
ISIN Code:                        SE0012675361            
----------------------------------------------------------
Order book id:                    132776                  
----------------------------------------------------------
Clearing:                         CCP Cleared             
----------------------------------------------------------
Segment:                          Mid cap                 
----------------------------------------------------------
Market segment:                   STO Equities CCP/182    
----------------------------------------------------------
Tick Size Table:                  MiFID II tick size table
----------------------------------------------------------
MIC:                              XSTO                    
----------------------------------------------------------


ICB Classification:

Industry code:     20 Health Care  
-----------------------------------
Supersector code:  2010 Health Care
-----------------------------------


For further information concerning this exchange notice please contact Issuer
Surveillance, telephone [phone], or [e-mail].